Neostigmine
| Use attributes for filter ! | |
| Formula | C12H19N2O2 |
|---|---|
| Molar mass | 223. 296 g/mol |
| CAS ID | 59-99-4 |
| Onset of action | Within 30 min (injection), with 4 hrs (by mouth) |
| Duration of action | up to 4 hrs |
| Trade name | Prostigmin, Vagostigmin, others |
| Music groups | Physostigmine |
| Atropine | |
| Pyridostigmine | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2078346 |
About Neostigmine
Neostigmine, sold under the brand name Prostigmin among others, is a medication used to treat myasthenia gravis, Ogilvie syndrome, and urinary retention without the presence of a blockage. It is also used together with atropine to end the effects of neuromuscular blocking medication of the non-depolarizing type.